SX Symptom Management (Platform/Oral)

Friday, May 31, 2013: 1:00 PM-3:00 PM
Lake Lucerne AB
1:00 PM
The Frequency of Asymptomatic UTIs in Persons With Multiple Sclerosis
Patricia A Pagnotta, ARNP, MSN, MSCN, CCRN, MS Center of Greater Orlando

1:20 PM
Educating MS Patients on CIC
Yolanda T Rodriguez, BSN, RN, MSCS, UTSW; Diana Logan, RN, FNP-C, BC, MSCN, UTSW; Victoria Stokes, RN, UTSW; Gina Remington, RN, BSN, MSCN, UTSW; Jaspreet Abraham, RN, BSN, MSCS, UTSW; Thomas Abraham, RN, BSN, MSCS, UTSW; Teresa Frohman, PA-C, MSCS, UTSW; Katherine Treadaway, LCSW, UTSW; Caroline Mooi, LMSW, UTSW; Megan Orchard, PA-C, UTSW; Samuel H Hughes, BS, UT Southwestern Medical Center; Elliot Frohman, MD, PhD, FAAN, UTSW

1:40 PM
Gastrointestinal Tolerability Events with BG-12 (Dimethyl Fumarate) in MS
Krzysztof Selmaj, MD, PhD, Medical University of Lodz, Lodz, Poland; Ralf Gold, MD, Ruhr University, Bochum, Germany; Robert J. Fox, MD, FAAN, Mellen Center for Multiple Sclerosis Treatment and Research, Cleveland Clinic; Eva Havrdova, MD, PhD, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic; Gavin Giovannoni, PhD, Blizard Institute, Barts and the London School of Medicine and Dentistry, London, UK; Amy Pace, ScD, Weston, MA, USA; Mark Novas, MD, Weston, MA, USA; Leslie Meltzer, PhD, Weston, MA, USA; Christophe Hotermans, MD, PhD, Weston, MA, USA; Katherine T. Dawson, MD, Weston, MA, USA; J. Theodore Phillips, MD PhD FAAN, Baylor Institute for Immunology Research, Dallas, TX, USA

2:00 PM
Use of PTM with Intrathecal Baclofen Pump Results in Better Spasticity Management
Shazia Siddiqui, MD, White River Medical Center; Meraj Siddiqui, MD, White River Medical Center; Annashia Shera, MD, university of Arkansas Medical Center

2:20 PM
A Randomized, Placebo-Controlled Study of Duloxetine for Pain in Multiple Sclerosis
Theodore R Brown, MD, MPH, Evergreen Health; April E Slee, MS, Axio Research

See more of: CMSC